KLRK1 and neoplasm: For example, the TKI axitinib and the anti-epileptic drug valproic acid have been reported to in vitro increase expression of NKG2D ligands on tumor cells, thereby increasing their susceptibility to NK cell and γδ T cell recognition [49, 50].